Trial intelligence / Profile preview

FIBCON: fibrinogen concentrate in paediatric cardiopulmonary bypass

ISRCTN50553029Phase 2Completed

Sponsor
Guy's and St Thomas' NHS Foundation Trust
Start
Jun 2014
Modality
Recombinant Proteins and Enzymes
01

Overview

Phase 2, randomised trial in Cardiovascular Malformation (CVM) comparing Fibrinogen concentrate with Placebo (2 arms). Primary endpoints: Fibrinogen concentration and Fibrin polymerization. Started Jun 2014; status: completed.

02

Drugs

Fibrinogen human
03

Conditions

Cardiovascular Malformation (CVM)

Beyond the preview

Go deeper on ISRCTN50553029.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN50553029.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call